ArticleJournal of atherosclerosis and thrombosis2020

Postprandial Glucose and Triglyceride Increases Along with the Endothelial Malfunction were Attenuated by the Administration of SGLT2 Inhibitor, Empagliflozin.

Daisaku Masuda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.